A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.
- Conditions
- NSCLC
- Registration Number
- NCT00269828
- Lead Sponsor
- CTI BioPharma
- Brief Summary
This is a randomized, open-label, multinational, phase III study in women with histologically- or cytologically-confirmed advanced NSCLC who are chemotherapy naรฏve and have PS 2. Study drug will be administered on day 1 of each 21 day cycle
- Detailed Description
See Summary
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- Female
- Target Recruitment
- 600
-
Female.
-
Histologically- or cytologically-confirmed diagnosis of NSCLC.
-
ECOG performance score of 2.
-
Patients who meet one of the following criteria:
- Stage IIIB who are not candidates for combined modality therapy (primary radiation therapy or surgery), or
- Stage IV.
-
Age greater than or equal to 18 years.
-
Adequate bone marrow function
-
Adequate renal function
-
Adequate hepatic function
-
Patients with known brain metastases must have received standard antitumor treatment for their CNS metastases as defined by the site's institutional standards.
-
Patients who have had major surgery must be fully recovered from the surgery.
-
Ability to comply with the visit schedule and assessments required by the protocol.
-
For patients of reproductive potential, commitment to use adequate contraception.
-
Signed approved informed consent, with understanding of study procedures.
-
Agreement to begin study therapy within 8 calendar days after randomization.
- Any intolerance to poly-L-glutamic acid, Poloxamer 188, dibasic sodium phosphate, monobasic sodium phosphate (the excipients of CT-2103).
- Evidence of small cell carcinoma, carcinoid, or mixed small cell/non-small cell histology.
- Any prior systemic chemotherapy for the treatment of lung cancer. This includes systemic radiosensitizers used to treat brain metastases and any biologic agent.
- Concurrent primary malignancies except for carcinoma in situ or non-melanoma skin cancer.
- Grade 2 or greater neuropathy.
- Evidence of significant unstable neurological symptoms within the 4 weeks before study randomization. (If unstable neurologic symptoms resulted from brain metastases, patient must meet inclusion criteria number 9).
- Clinically significant active infection for which active therapy is underway.
- Investigational therapy within 4 weeks before randomization, unless local requirements are more stringent.
- Unstable medical conditions including unstable angina or myocardial infarction within the past 6 months before randomization. Patients with evidence of cardiac conduction abnormalities are eligible if their cardiac status is stable.
- Pregnant women or nursing mothers.
- Any circumstance at the time of study entry that would preclude completion of the study or the required follow-up.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method The primary objective of this study is to compare the overall survival of female patients randomized to CT-2103 to that of female patients randomized to paclitaxel.
- Secondary Outcome Measures
Name Time Method Secondary objectives are to compare the progression-free survival, response rate, disease control, clinical benefit, quality of life, and the safety and tolerability of the treatment arms.
Trial Locations
- Locations (142)
Hospital General de Agudos "Dr Teodoro Alvarez"
๐ฆ๐ทBuenos Aires, Argentina
LUCEN
๐ฆ๐ทCuidad Autonoma de Buenos Aires, Argentina
ISIS Clinica Especializada
๐ฆ๐ทUrquiza, Argentina
Regional Oncology Dispensary with Inpatient sector
๐ง๐ฌVeliko Tarnovo, Bulgaria
Jewish General Hospital
๐จ๐ฆMontreal, Quebec, Canada
University of Debrecen, Pulmonology Clinic
๐ญ๐บDebreen, Hungary
Arizona Hematology Oncology
๐บ๐ธTucson, Arizona, United States
District Oncology Dispensary
๐ง๐ฌPlovdiv, Bulgaria
Columbia Basin HEM/ONC
๐บ๐ธKennewick, Washington, United States
CETEN
๐ฆ๐ทBeunos Aires, Argentina
Regional Oncology Dispensary with Inpatient Secot-Sofia District
๐ง๐ฌSogia, Bulgaria
Oncology Pharmacy
๐ฌ๐งLondon, United Kingdom
Sanatorio Parque
๐ฆ๐ทRosario, Santa Fe, Argentina
Instituto Alexander Fleming
๐ฆ๐ทCiudad de Buenos Aires, Argentina
JPS Center for Cancer Care
๐บ๐ธFort Worth, Texas, United States
Erzsebet Hospital
๐ญ๐บSopron, Hungary
Wythenshaw Hospital, Pharmacy Department
๐ฌ๐งManchester, United Kingdom
CIMA Chihuahua
๐ฒ๐ฝChihuahua, Chih, Mexico
Hospital General
๐ฒ๐ฝDurango, Dgo., Mexico
Instituto Estatal de Cancerologia "Dr. Arturo Beltran Ortega"
๐ฒ๐ฝAcapulco, Gro, Mexico
Chelyabinsk Regional Oncology Center
๐ท๐บChelyabinsk, Russian Federation
Krasnodar City Oncology Center
๐ท๐บKrasnodar, Russian Federation
The Royal Bournemouth Hospital
๐ฌ๐งBournemouth, United Kingdom
Southhampton General Hospital
๐ฌ๐งSouthhampton, United Kingdom
Zaporizhzhya Regional Oncology Dispensary
๐บ๐ฆZaprizhzhya, Ukraine
Comprehensive Blood and Cancer Center
๐บ๐ธBakersfield, California, United States
West Kentucky Hematology & Oncology Group, PSC
๐บ๐ธPaducah, Kentucky, United States
New York Medical Collegw
๐บ๐ธValhalla, New York, United States
University of Cleveland
๐บ๐ธCleveland, Ohio, United States
The Cleveland Clinic Foundation, Taussig Cancer Center
๐บ๐ธCleveland, Ohio, United States
Mary Crowley Medical Research Center
๐บ๐ธDallas, Texas, United States
Pacific Cancer Medical Center, Inc
๐บ๐ธAnaheim, California, United States
Tower Cancer Research Foundation
๐บ๐ธBeverly Hills, California, United States
Providence St. Joseph Medical Center
๐บ๐ธBurbank, California, United States
Hematology/Oncology Group of Fresno, Inc
๐บ๐ธFresno, California, United States
Comprehensive Cancer Center-Research Office
๐บ๐ธGlendale, California, United States
Loma Linda University Cancer Institute
๐บ๐ธLoma Linda, California, United States
Pacific Shores Medical Group
๐บ๐ธLong Beach, California, United States
Medical Oncology Care Associates
๐บ๐ธOrange, California, United States
The Cancer Research and Prevention Center
๐บ๐ธSoquel, California, United States
Bethesda Research Center
๐บ๐ธBoynton Beach, Florida, United States
Florida Wellcare
๐บ๐ธInverness, Florida, United States
Broward Oncology Associates
๐บ๐ธFort Lauderdale, Florida, United States
Oncology-Hematology Associates of West Broward
๐บ๐ธTamarac, Florida, United States
Cancer & Blood Disease Center
๐บ๐ธLecanto, Florida, United States
Joliet Oncology Hematology Associates, Ltd.
๐บ๐ธJoliet, Illinois, United States
Loyola University Health Systems
๐บ๐ธMaywood, Illinois, United States
Mid-Illinois HEM & ONC Assoc.
๐บ๐ธNormal, Illinois, United States
Northern Indiana Cancer Research Consortium
๐บ๐ธSouth Bend, Indiana, United States
Associated Physicians & Surgeons Clinic
๐บ๐ธTerre Haute, Indiana, United States
Kentucky Cancer Clinic
๐บ๐ธHazard, Kentucky, United States
West Michigan Cancer Center
๐บ๐ธKalamazoo, Michigan, United States
Oncology Care Associates, PLLC
๐บ๐ธSaint Joseph, Michigan, United States
St. Louis Cancer Care Center
๐บ๐ธChesterfield, Missouri, United States
Columbia Comprehensive Cancer Care Clinics
๐บ๐ธColumbia, Missouri, United States
Bond Clinic
๐บ๐ธRolla, Missouri, United States
Washington University Siteman Cancer Center Pharmacy
๐บ๐ธSaint Louis, Missouri, United States
Our Lady of Mercy Medical Center
๐บ๐ธBronx, New York, United States
Suny Downstate Medical Center
๐บ๐ธBrooklyn, New York, United States
Interlakes Foundation, Inc.
๐บ๐ธRochester, New York, United States
UNC Chapel Hill Oncology Protocol Office
๐บ๐ธChapel Hill, North Carolina, United States
Alamance Cancer Center
๐บ๐ธBurlington, North Carolina, United States
Leo Jenkins Cancer Center
๐บ๐ธGreenville, North Carolina, United States
Northwestern Carolina Oncology & Hematology
๐บ๐ธHickory, North Carolina, United States
St. Alexius Medical Center
๐บ๐ธBismarck, North Dakota, United States
Metro Health Medical Center
๐บ๐ธCleveland, Ohio, United States
Signal Point Hematology/Oncology, Inc.
๐บ๐ธMiddletown, Ohio, United States
Centenario Hospital Miguel Hidalgo
๐ฒ๐ฝAguascalientes, Ags., Mexico
Hospital Star Medica Morelina
๐ฒ๐ฝMorelia, Michoacan, Mexico
Hospital General Regional
๐ฒ๐ฝVeracruz, Mexico
Kujawsko-Pomorskie Centrum Pulmunologii
๐ต๐ฑBydgoszcz, Poland
SPSK nr l im. Przemienienia AM w Poznaniu
๐ต๐ฑPoznan, Poland
Dolnoslaskie Centrum Chorob Pluc ul. Grabiszynska 105
๐ต๐ฑWroclaw, Poland
Prof. Dr. Al. Trestioreanu Institute of Oncology
๐ท๐ดBucharest, Romania
Emergency Clinical County Hospital
๐ท๐ดCraiova, Romania
Oradea Clinical County Hospital
๐ท๐ดOradea, Romania
SI Russian Oncological Scientific Center after N.N. Blokhim RAMS
๐ท๐บMoscow, Russian Federation
Volyn Regional Oncology Dispensary
๐บ๐ฆLutsk, Ukraine
Hospital for Thoracic Diseases of Csongrad Country
๐ญ๐บDeszk, Hungary
Pulmonology Institute of Veszprem County
๐ญ๐บFarkasgyepu, Hungary
Barany County Hospital
๐ญ๐บPecs, Hungary
Hospital Central "Dr. Ignacio Morones Prieto"
๐ฒ๐ฝSan Luis Potosi, Mexico
MSc Grezegorz Jedrejezak
๐ต๐ฑWroclaw, Poland
"Prof. Dr. I. Chiricuta" Institute of Oncology
๐ท๐ดCluj-Napoca, Romania
Moscow Municpal Oncology Hospital #62
๐ท๐บMoscow Region, Russian Federation
Omsk Regional Oncology Center
๐ท๐บOmsk, Russian Federation
Orenburg Regional Oncology Clinical Center
๐ท๐บOrenburg, Russian Federation
Donetsk Regional Antineoplastic Center
๐บ๐ฆDonetsk, Ukraine
University Mulitprofile Hospital for Active Treatment "Sveta Marina"
๐ง๐ฌVarna, Bulgaria
Heritage Physician Group, Oncology
๐บ๐ธHot Springs, Arkansas, United States
Essex Oncology of North Jersey, PA
๐บ๐ธBelleville, New Jersey, United States
Hospital of the Chest Desease of the Hungarian Reformed Church
๐ญ๐บMosdos, Hungary
Karolina Hospital
๐ญ๐บMosonmagyarovar, Hungary
Krakowski Szpital Specjelistyczny
๐ต๐ฑKawkow, Poland
Institutul Oncologie - Clinic de Oncologie Medicala
๐ท๐ดBucharest, Romania
Timisoara Emergency Clinical Municipal Hospital
๐ท๐ดTimisoara, Romania
St. Petersbrug State Medical Pavlov University
๐ท๐บSt. Petersburg, Russian Federation
Uzhgorod National University, Regional Clinical Oncology Dispensary
๐บ๐ฆUzhgorod, Ukraine
Regional Oncology Dispensary with Inpatient Sector
๐ง๐ฌVarna, Bulgaria
Montana Cancer Specialists
๐บ๐ธMissoula, Montana, United States
Genesis Cancer Center
๐บ๐ธHot Springs, Arkansas, United States
Erzsebet Juhasz
๐ญ๐บBudapest, Hungary
Centeral ClinicalHospital of the President o the Russian Federation
๐ท๐บMoscow, Russian Federation
Atlanta HEM ONC
๐บ๐ธManasquan, New Jersey, United States
Cabrini Center for Cancer Care
๐บ๐ธAlexandria, Louisiana, United States
Instituto Oncologico de Cordoba - IONC
๐ฆ๐ทCordoba, Argentina
Hospital for Pulmonological Diseases of the Bekes County
๐ญ๐บGyula, Hungary
Sanatorium for Pulmonological Diseases
๐ญ๐บTorokbalint, Hungary
Desert Oasis Cancer Center
๐บ๐ธCasa Grande, Arizona, United States
Oncology and Hematology Specialist, PA
๐บ๐ธMountain Lakes, New Jersey, United States
Hospital Privado de Comunidad
๐ฆ๐ทBuenos Aires, Argentina
District Oncolodispensary with Impatient sector
๐ง๐ฌRousse, Bulgaria
Military Medical Academy
๐ง๐ฌSofia, Bulgaria
Centro Estatal de Cancerologia
๐ฒ๐ฝChihuahua, Mexico
Charleston Hematology Oncology
๐บ๐ธCharleston, South Carolina, United States
Centro Anticanceroso de la Cruz Roja Mexicana de Merida
๐ฒ๐ฝMerida, Yucatan, Mexico
Instiute of Oncology under AMS of Ukraine
๐บ๐ฆKiev, Ukraine
Centrum Onkologii Ziemii Lubelskiej
๐ต๐ฑLublin, Poland
University Multiprofile Hospital for Active Treatment "Sveta Marina"
๐ง๐ฌVarna, Bulgaria
Monterrey International Research Center
๐ฒ๐ฝMonterrey, N.l., Mexico
Centro Estatal de Canceologia
๐ฒ๐ฝJalapa, Veracruz, Mexico
St. Petersburg City Clinical Oncology Center
๐ท๐บSaint Petersburg, Russian Federation
Ivano-Frankovsk Regional Oncology Center, Ivano-Frankovsk Medical University
๐บ๐ฆIvano-Frankovsk, Ukraine
Vinnitsa State Medical University
๐บ๐ฆVynnytsya, Ukraine
Moscow Oncology Clinical Dispensary #1
๐ท๐บMoscow, Russian Federation
SI Russian Oncological Scientific Center after N.N. Blokhin RAMS
๐ท๐บMoscow, Russian Federation
Zaklad Opieki Zdrowotnej Ministerstaw Spraw Wewnetrznych i Administraeji
๐ต๐ฑOlsztyn, Poland
Mazowleckie Centrum leczenia Chorob Pluc i Gruzlicy
๐ต๐ฑOtwock, Poland
Clinical County Hospital
๐ท๐ดSibiu, Romania
Wielkopolskie Centrum Chorob Pluc i Gruzlicy, Samodzielmy Publiczny ZOZ
๐ต๐ฑPoznan, Poland
Lenigrad Regional Oncology Center
๐ท๐บSt. Petersburg, Russian Federation
Leningrad Regional Clinical Hospital
๐ท๐บSt. Petersburg, Russian Federation
Saint Louis University
๐บ๐ธSaint Louis, Missouri, United States
Cancer Treatment Services
๐บ๐ธCorning, New York, United States
Guthrie Clinic
๐บ๐ธSayre, New York, United States
Hubert H. Humphrey Cancer Center
๐บ๐ธRobbinsdale, Minnesota, United States
San Juan Oncology Association
๐บ๐ธFarmington, New Mexico, United States
Hematology Oncology Speaclist
๐บ๐ธTampa, Florida, United States
Dayton Clinical Oncology Program
๐บ๐ธDayton, Ohio, United States
The Family Cancer Center
๐บ๐ธCollierville, Tennessee, United States
Sierra Nevada Oncology Care
๐บ๐ธCarson City, Nevada, United States
Hospital Dr. Angel Leano
๐ฒ๐ฝZapopan, Jalisco, Mexico